Annual performance report, Prescription Drug User Fee Act of 1992 fiscal year : ... report to Congress / prepared by FDA's Office of Planning and Evaluation in collaboration with the Center for Biologics Evaluation and Research (CBER) and the Center for Drug Evaluation and Research (CDER).

Format:

Government document

Journal/Periodical

Contributor:

United States. Food and Drug Administration. Office of Planning and Evaluation

Center for Biologics Evaluation and Research (U.S.)

Center for Drug Evaluation and Research (U.S.)

United States. Food and Drug Administration

Language:

English

Subjects (All):

United States. Prescription Drug User Fee Act of 1992.

United States.

Prescription Drug User Fee Act of 1992 (United States).

Pharmaceutical industry--United States--Periodicals.

Pharmaceutical industry.

Drugs--Law and legislation--United States--Periodicals.

Drugs.

Drugs--Testing--Periodicals.

Drugs--Law and legislation.

Drugs--Testing.

Genre:

Periodicals.

Physical Description:

Annual

-fiscal year 1997.

Other Title:

Issue for Fiscal year 1997 has title: Final performance report, Prescription Drug User Fee Act of 1992

Report to Congress

Continued By:

FY ... performance report to Congress for the Prescription Drug User Fee Act of 1992 as amended by the Food and Drug Administration Modernization Act of 1997

Place of Publication:

[Washington, D.C.] : Food and Drug Administration, Public Health Service, Dept. of Health and Human Services, -1997.

System Details:

Mode of access: Internet from the FDA web site. Address as of 3/22/04: http://www.fda.gov/oc/pdufa/reports.html; current access is available via PURL.

Notes:

Description based on: Fiscal year 1995; title from title screen (viewed Mar. 22, 2004).

Other Format:

Annual performance report Prescription Drug User Fee Act of 1992

OCLC:

54910318